Results 191 to 200 of about 1,686,414 (204)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2021
Hana M El Sahly, Brandon Essink, Karen L Kotloff   +2 more
exaly  

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Lancet, The, 2021
Noam Barda, Noa Dagan, Cyrille J Cohen
exaly  

Development of an mRNA-lipid nanoparticle vaccine against Lyme disease

Molecular Therapy, 2023
Norbert Pardi
exaly  

Thoughts on mRNA Vaccine Response

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy, 2023
openaire   +2 more sources

mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection

International Journal of Molecular Sciences, 2020
Lu Zhang
exaly  

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients

Cell Reports, 2021
Cristina Bergamaschi, Evangelos Terpos, Margherita Rosati   +2 more
exaly  

Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers

Nature Biomedical Engineering
Di Yin, Yiye Zhong, Sikai Ling, Sicong Lu, Xiaoyuan Wang, Zhuofan Jiang, Jie Wang, Yao Dai, Xiao-long Tian, Qijing Huang, Xingbo Wang, Junsong Chen, Ziying Li, Yang Li, Zhijue Xu, Hewei Jiang, Yuqing Wu, Yi Shi, Quanjun Wang, Jianjiang Xu, W. Hong, Heng Xue, Hang Yang, Yan Zhang, Lintai Da, Ze-Guang Han, Sheng-ce Tao, Ruijiao Dong, Tianlei Ying, Jiaxu Hong, Yujia Cai   +30 more
semanticscholar   +1 more source

mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases

Molecular Therapy, 2019
Giulietta Maruggi, Cuiling Zhang, Junwei Li   +2 more
exaly  

Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer

Molecular Therapy, 2018
Yuhua Wang, Lei Miao, Qi Liu
exaly  

mRNA-vaccine

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
Yuta Tanaka, Yoshito Zamami
openaire   +1 more source